Live Breaking News & Updates on First Chikungunya Vaccine

Stay updated with breaking news from First chikungunya vaccine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Valneva Receives EMA's Positive CHMP Opinion for its Chikungunya Vaccine

Valneva Receives EMA's Positive CHMP Opinion for its Chikungunya Vaccine
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New York , United States , United Kingdom , Joshua Drumm , Instituto Butantan , Richard Hatchett , Juan Carlos Jaramillo , Health Information For International , Oxford University , European Commission , Centers For Disease , Vp Global Communications European Investor Relations , Brazilian Health Regulatory Agency , European Union , Committee For Medicinal Products Human Use , Health Canada , European Union Horizon , European Medicines Agency , Oxford University Press , Drug Administration , Coalition For Epidemic Preparedness Innovations , International Recognition Procedure , Regulatory Agency , Euronext Paris , Medicinal Products , Human Use ,

Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer

Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Noord Holland , Thomas Lingelbach , Hanneke Schuitemaker , Joshua Drumm , Amsterdam University Medical Center , Netherland Blood Supply Foundation , Vp Global Communications European Investor Relations , Euronext Paris , Chief Scientific Officer , Executive Committee , Executive Team , Global Head , Viral Vaccine Discovery , Translational Medicine , Chief Executive Officer , First Chikungunya Vaccine ,

Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine

Saint-Herblain , January 10, 2024 – Valneva SE today announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of. ....

Dominican Republic , New York , United States , Instituto Butantan , Joshua Drumm , Juan Carlos Jaramillo , Vp Global Communications European Investor Relations , European Union Horizon , Brazilian Health Regulatory Agency Anvisa , Health Information For International , European Medicines Agency , Centers For Disease , Oxford University Press , Oxford University , Health Canada , Drug Administration , Euronext Paris , Chief Medical Officer , Brazilian Health Regulatory Agency , Southeast Asia , Middle Income Countries , European Union , Prescribing Information , Reports Positive Pivotal Phase , Single Shot Chikungunya Vaccine Candidate , First Chikungunya Vaccine ,

Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine

Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Dominican Republic , New York , United States , Joshua Drumm , Juan Carlos Jaramillo , Instituto Butantan , Health Canada , Drug Administration , Vp Global Communications European Investor Relations , Oxford University , European Union Horizon , Centers For Disease , Health Information For International , Oxford University Press , Brazilian Health Regulatory Agency Anvisa , European Medicines Agency , Euronext Paris , Chief Medical Officer , Brazilian Health Regulatory Agency , Southeast Asia , Middle Income Countries , European Union , Prescribing Information , Reports Positive Pivotal Phase , Single Shot Chikungunya Vaccine Candidate , First Chikungunya Vaccine ,

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum -January 04, 2024 at 11:46 am EST

Saint-Herblain , January 4, 2024 – Valneva SE , a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold. ....

San Francisco , United States , Thomas Lingelbach , Joshua Drumm , Vp Global Communications European Investor Relations , Forum On , Euronext Paris , Healthcare Conference , Prescribing Information , First Chikungunya Vaccine ,